PDCI Market Access, a Division of McKesson Canada Corporation has released a whitepaper investigating the design and sustainability of private drug benefits in Canada. The report, commissioned by Innovative Medicines Canada, uncovers critical gaps in private insurance risk pooling that leave many small plan sponsors with tough decisions ... Read More